Evolve Private Wealth LLC Makes New Investment in Encompass Health Corporation $EHC

Evolve Private Wealth LLC bought a new stake in shares of Encompass Health Corporation (NYSE:EHC) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 8,781 shares of the company’s stock, valued at approximately $888,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Encompass Health by 3,059,159.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after purchasing an additional 3,793,358 shares during the period. AlphaCore Capital LLC purchased a new position in Encompass Health in the 4th quarter worth about $4,881,000. Systematic Financial Management LP lifted its holdings in Encompass Health by 3.6% during the 4th quarter. Systematic Financial Management LP now owns 440,752 shares of the company’s stock valued at $46,782,000 after buying an additional 15,462 shares in the last quarter. Trillium Asset Management LLC lifted its holdings in Encompass Health by 5.7% during the 4th quarter. Trillium Asset Management LLC now owns 217,734 shares of the company’s stock valued at $23,424,000 after buying an additional 11,793 shares in the last quarter. Finally, Global Retirement Partners LLC boosted its position in Encompass Health by 2,468.6% in the 4th quarter. Global Retirement Partners LLC now owns 11,533 shares of the company’s stock valued at $1,224,000 after buying an additional 11,084 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Encompass Health

In related news, EVP John Patrick Darby sold 8,906 shares of the business’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the completion of the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at $9,451,413.95. The trade was a 10.61% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the sale, the chief executive officer owned 267,814 shares in the company, valued at approximately $33,602,622.58. This trade represents a 39.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.80% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on EHC shares. UBS Group upped their price target on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. TD Cowen boosted their target price on Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Leerink Partners set a $152.00 target price on Encompass Health in a research report on Friday, May 22nd. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, August 16th. Finally, Weiss Ratings raised Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus target price of $148.71.

Encompass Health Stock Down 0.1%

EHC stock opened at $120.24 on Monday. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.19 and a current ratio of 1.19. The firm’s fifty day moving average is $111.01 and its 200 day moving average is $106.47. The firm has a market cap of $11.86 billion, a PE ratio of 19.58, a P/E/G ratio of 2.43 and a beta of 0.72.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, research analysts forecast that Encompass Health Corporation will post 6.09 EPS for the current year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a dividend of $0.21 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 1st. Encompass Health’s dividend payout ratio is currently 12.38%.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.